Impact of the COVID-19 pandemic on incident diagnoses in German refugee centres 2018 to 2023.

Publication date: Jul 24, 2025

The COVID-19 pandemic may have affected morbidity patterns of residents in refugee centres, but empirical evidence is scarce. We utilised linked data from a health surveillance network in refugee centres of three German federal states, employing a quasi-experimental design to examine the effects of the COVID-19 pandemic on newly diagnosed medical conditions. Doctors coded routine diagnoses on-site in healthcare facilities for refugee patients. Our analysis encompasses the timeframe from October 2018 to April 2023 and includes individual-level data for 109,175 refugees. This data resulted in 76,289 patient-months across 21 refugee centres, with a total occupancy of 144,012 person-months. Here, we employ segmented regression analyses, adjusting for time trends, socio-demographic factors, occupancy, and centre characteristics, to evaluate the COVID-19 pandemic’s impact on incident diagnosis patterns among refugees. We show how the COVID-19 pandemic altered diagnosis patterns among refugees in German centres. Notably, incidents of injuries, mental disorders, psychotherapeutic drug prescriptions, and genitourinary diseases rose, while respiratory diseases decreased, later rebounding. An increase in injury-related diagnoses suggests heightened violence experiences during flight or in centres. Mental disorder diagnoses and psychotherapeutic drug prescriptions rose, reflecting pandemic-related stressors and the pandemic’s multifaceted impact on refugee health.

Open Access PDF

Concepts Keywords
April Adolescent
German Adult
Healthcare Child
Refugee COVID-19
Female
Germany
Humans
Incidence
Male
Mental Disorders
Middle Aged
Pandemics
Refugees
SARS-CoV-2
Young Adult

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH morbidity
disease IDO site
disease MESH mental disorders
disease MESH genitourinary diseases
disease MESH respiratory diseases
disease MESH violence
drug DRUGBANK Cysteamine
drug DRUGBANK Cyclic Adenosine Monophosphate
disease MESH uncertainty
disease IDO intervention
disease MESH non communicable diseases
disease MESH infectious diseases
drug DRUGBANK Timonacic
disease MESH causes
disease MESH parasitic diseases
disease IDO blood
disease IDO facility
disease MESH Neoplasm
disease MESH Hypertension
disease MESH measles
pathway KEGG Measles
disease MESH chicken pox
disease MESH Infection
disease IDO country
disease MESH metabolic diseases
disease IDO process
disease MESH Diabetes Mellitus
disease MESH privacy
disease MESH urinary tract infections
disease MESH kidney disease
disease MESH complications
disease MESH acute kidney injury
disease MESH emergencies
drug DRUGBANK Serine
drug DRUGBANK Indoleacetic acid
disease IDO host
disease IDO quality
disease MESH chronic conditions
disease IDO history
disease MESH Skin Diseases
disease MESH Blood Diseases
drug DRUGBANK Fenamole
drug DRUGBANK Aspartame

Original Article

(Visited 1 times, 1 visits today)